Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
13.21
+0.35 (2.72%)
Apr 29, 2026, 12:48 PM EDT - Market open
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $352.90 million as of April 29, 2026. Its market cap has increased by 574.75% in one year.
Market Cap
352.90M
Enterprise Value
245.64M
1-Year Change
574.75%
Ranking
Category
Stock Price
$13.21
Market Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $352.90M, an increase of 922.89%. That is a compound annual growth rate of 24.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 293.10M | -10.99% |
| Dec 31, 2025 | 329.30M | 326.55% |
| Dec 31, 2024 | 77.20M | 957.53% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monopar Therapeutics | 364.59M |
| Silence Therapeutics | 363.70M |
| Armata Pharmaceuticals | 357.54M |
| Opus Genetics | 357.01M |
| Surrozen | 355.86M |
| Immuneering | 338.37M |
| DiaMedica Therapeutics | 335.15M |
| Compass Therapeutics | 331.36M |